Last reviewed · How we verify
NCT06057896
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
trial testing inositol, phytoestrogens, cocoa polyphenols in Menopause in 200 participants. Completed in 15 August 2023.
30 June 2023
Quick facts
| Lead sponsor | Lo.Li.Pharma s.r.l |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 30 September 2022 |
| Primary completion | 30 June 2023 |
| Estimated completion | 15 August 2023 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- inositol, phytoestrogens, cocoa polyphenols
Conditions studied
- Menopause — all drugs for Menopause →
- Climacteric Syndrome — all drugs for Climacteric Syndrome →
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
Sponsor
Lo.Li.Pharma s.r.l
Who can join
Adults 45 to 60, female only, with Menopause or Climacteric Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study collected retrospective data from the assumption of combined natural molecules in menopausal women with metabolic syndrome
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Dietary Supplementation of Myo-Inositol, Cocoa Polyphenols, and Soy Isoflavones Improves Vasomotor Symptoms and Metabolic Profile in Menopausal Women with Metabolic Syndrome: A Retrospective Clinical Study.
Mainini G, Ercolano S, De Simone R, Iavarone I, et al · · 2024 · cited 5× · PMID 38674244 · DOI 10.3390/medicina60040598
Verify or expand the search:
- PubMed search for NCT06057896
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Menopause
Currently open trials in the same condition.
- NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
- NCT07135232 — The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. · NA · recruiting
- NCT06975111 — Focusing on the Menopausal Transition to Improve Mid-Life Women's Health · Phase 2, PHASE3 · recruiting
- NCT07393672 — Effects of Hemp-Derived Cannabinoids on Menopause Symptoms · Phase 2 · recruiting
- NCT07412093 — The Effect of Progressive Relaxation Exercises and Planned Education on Menopausal Symptoms, Perceived Stress, and Anxie · NA · active not recruiting
Other Lo.Li.Pharma s.r.l trials
Trials by the same sponsor.
- NCT07257770 — Local Treatment of Breast Pain Based on the Daily Use of a Topical Gel · NA · recruiting
- NCT06715527 — Treatment of Women With Hyperandrogenic PCOS With Two Different Ratios of Myo-inositol:D-chiro-inositol: A Comparison · NA · completed
- NCT06639698 — Treatment of Women With PCOS of Phenotype D · NA · completed
- NCT05674318 — The Effect of Alpha-lactalbumin on Microbiota Composition · NA · completed
- NCT05678114 — Inositol Treatment in Different Type of PCOS Phenotype · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06057896 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lo.Li.Pharma s.r.l
- Last refreshed: 8 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06057896.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing